Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Aβ1‐6 upregulates IL‐10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease
- 12 January 2007
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 9 (2) , 88-98
- https://doi.org/10.1002/jgm.993
Abstract
Background One of the pathological hallmarks of Alzheimer's disease (AD) is deposits of amyloid β‐peptide (Aβ) in neuritic plaques and cerebral vessels. Immunization of AD mouse models with Aβ reduces Aβ deposits and improves memory and learning deficits. Because recent clinical trials of immunization with Aβ were halted due to brain inflammation that was presumably induced by a T‐cell‐mediated autoimmune response, vaccination modalities that elicit predominantly humoral immune responses are currently being developed. Methods We have nasally immunized a young AD mouse model with an adenovirus vector encoding 11 tandem repeats of Aβ1‐6 fused to the receptor‐binding domain (Ia) of Pseudomonas exotoxin A (PEDI), AdPEDI‐(Aβ1‐6)11, in order to evaluate the efficacy of the vector in preventing Aβ deposits in the brain. We also have investigated immune responses of mice to AdPEDI‐(Aβ1‐6)11. Results Nasal immunization of an AD mouse model with AdPEDI‐(Aβ1‐6)11 elicited a predominant IgG1 response and reduced Aβ load in the brain. The plasma IL‐10 level in the AD mouse model was upregulated after immunization and, upon the stimulation with PEDI‐(Aβ1‐6)11, marked IL‐10 responses were found in splenic CD4+ T cells from C57BL/6 mice that had been immunized with AdPEDI‐(Aβ1‐6)11. Conclusions These results suggest that the induction of Th2‐biased responses with AdPEDI‐(Aβ1‐6)11 in mice is mediated in part through the upregulation of IL‐10, which inhibits activation of dendritic cells that dictate the induction of Th1 cells. Copyright © 2007 John Wiley & Sons, Ltd.Keywords
This publication has 78 references indexed in Scilit:
- Of mice and men: more neurobiology in dementiaCurrent Opinion in Psychiatry, 2006
- Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Aβ1–6: Toward safer and effective vaccines against Alzheimer’s diseaseBiochemical and Biophysical Research Communications, 2005
- Meningoencephalitis associated with passive immunization of a transgenic murine model of Alzheimer's amyloidosisFEBS Letters, 2005
- Exacerbation of Cerebral Amyloid Angiopathy-Associated Microhemorrhage in Amyloid Precursor Protein Transgenic Mice by Immunotherapy Is Dependent on Antibody Recognition of Deposited Forms of Amyloid βJournal of Neuroscience, 2005
- Induction of low dose oral tolerance in IL-10 deficient mice with experimental autoimmune encephalomyelitisJournal of Autoimmunity, 2004
- Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zoneDevelopment, 2004
- Association of Aortic Atherosclerosis with Cerebral β-Amyloidosis and Learning Deficits in a Mouse Model of Alzheimer's DiseaseThe American Journal of Pathology, 2003
- Cerebral Hemorrhage After Passive Anti-Aβ ImmunotherapyScience, 2002
- Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic CellsThe Journal of Experimental Medicine, 2002
- Genetic Immunotherapy of Established Tumors with Adenovirus-Murine Granulocyte-Macrophage Colony-Stimulating FactorHuman Gene Therapy, 1997